Director/PDMR Dealing
8 October 2024
Calnex Solutions plc
(the "Company")
Director / PDMR Dealing
Calnex Solutions plc (AIM: CLX), an established provided of test and measurement solutions for the global telecommunications sector, confirms the following transactions in the Company's ordinary shares.
The information in the below notification is disclosed in accordance with Article 19 of the EU Market Abuse Regulation.
1 | Details of PDMR/person closely associated with them ("PCA") | |||||
1.1 | Name | Graeme Bissett | ||||
1.2 | Position/Status | Non-Executive Director | ||||
1.3 | Initial notification / amendment | Initial notification | ||||
2 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
2.1 | Name | Calnex Solutions plc | ||||
2.2 | LEI | 213800GY6TURGL3HYT04 | ||||
3 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
3.1 | Description of the financial instrument Identification code | Ordinary shares of 0.125 pence each
| ||||
3.2 | Nature of the transaction | Purchase of Ordinary Shares | ||||
3.3 | Price(s) and volume(s) |
| ||||
3.4 | Aggregated information · Aggregated volume · Price |
39,299
£19,998.87 | ||||
3.5 | Date of the transaction | 4th October 2024 | ||||
3.6 | Place of the transaction | London Stock Exchange (AIM:CLX) | ||||
For more information, please contact:
Calnex Solutions plc | Via Alma |
Tommy Cook, Chief Executive Officer Ashleigh Greenan, Chief Financial Officer | |
Cavendish Capital Markets Limited - NOMAD | +44 (0)131 220 6939 |
Derrick Lee, Peter Lynch | |
Alma | + 44(0) 20 3405 0213 |
Caroline Forde, Joe Pederzolli, Emma Thompson |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.